Word: fda
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
Worries about the perils of cloning are heading from the fire to the frying pan. After studying the dangers of allowing food products derived from clones and their offspring into the U.S. food chain, the FDA has issued a preliminary report declaring them just as safe to eat as those from any other animal. The current moratorium against selling food from clones will remain in effect for now, but the national debate may be just heating...
...commissioner of the Food and Drug Administration (FDA) and the Massachusetts attorney general sparred over the re-importation of prescription drugs from Canada in speeches made during a conference at Harvard Business School this weekend...
...FDA Commissioner Mark B. McClellan defended his administration’s current policies against barbs from Mass. Attorney General Tom Reilly, who in a speech following McClellan’s reiterated his calls for the FDA to reconsider its policy of prohibiting re-importation...
Hell, why stop at silencing dissent when you can fabricate agreement? Earlier this year the FDA released a paper addressing the controversial issue of direct-to-consumer (DTC) advertising by pharmaceutical companies, which is often charged with misleading consumers. The FDA paper claimed that, according to a recent survey of physicians, “most [physicians] agreed that, because their patients saw a DTC ad, he or she asked more thoughtful questions during the visit.” This claim is actually accurate—if by “most” physicians, the FDA meant four percent...
...there is so much interest in a new study sponsored by the drugmaker Sepracor and led by Dr. Andrew Krystal, director of Duke University's Sleep Research Laboratory and Insomnia Clinic. It monitored users of a Sepracor pill called Estorra (currently under review for approval by the FDA) in a double-blind, placebo-controlled study for six months and concluded that the drug was safe and effective for nightly use. Expect to see competitors testing long-term use of their sleep drugs...